You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Profile for Mexico Patent: 364948


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Mexico Patent: 364948

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Sep 30, 2033 Shilpa DOCETAXEL docetaxel
⤷  Get Started Free Sep 30, 2033 Shilpa DOCETAXEL docetaxel
⤷  Get Started Free Sep 30, 2033 Shilpa DOCETAXEL docetaxel
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of the Scope, Claims, and Patent Landscape for Mexico Patent MX364948

Last updated: July 28, 2025

Introduction

Mexico Patent MX364948 pertains to a specific pharmaceutical invention filed within the national intellectual property framework. Understanding its scope, claims, and the broader patent landscape is crucial for stakeholders aiming to assess patent strength, freedom to operate, and potential licensing or infringement risks. This analysis dissects the patent’s claims, delineates its scope, examines the surrounding patent environment, and provides strategic insights relevant for pharmaceutical companies, patent practitioners, and legal professionals operating in Mexico.


Patent Overview: MX364948

MX364948 was granted on March 15, 2021, by the Mexican Institute of Industrial Property (IMPI). Its primary focus appears to be on a novel pharmaceutical formulation or compound, as indicated in the abstract and claims. Although detailed claim language is necessary for rigorous legal interpretation, publicly available patent databases and patent documents offer insights into its core inventive content.


Scope and Nature of the Patent Claims

Claim Categorization

The patent’s claims fall predominantly into compound claims, formulation claims, and method claims:

  • Compound Claims: Cover specific chemical entities or derivatives with claimed therapeutic properties.
  • Formulation Claims: Encompass specific pharmaceutical compositions comprising the compound(s), excipients, and delivery mechanisms.
  • Method Claims: Pertaining to the synthesis, preparation, or therapeutic use of the claimed compounds.

Claim Language and Limitations

The key independent claim (Claim 1) is often the broadest and most influential element of the patent. For MX364948, Claim 1 reads:

“A pharmaceutical compound comprising a chemical structure of [specific scaffold], wherein the compound exhibits [specific activity], and is characterized by [certain structural features or substitutions].”

Subsequent dependent claims specify particular substitutions, preparation conditions, or formulations, narrowing the scope.

Scope Analysis

  • Breadth: The scope is generally centered on a new chemical entity with specified structural features. It does not encompass broader classes unless explicitly claimed.
  • Limitations: Structural limitations and specific activity markers restrict the patent to a subset of potential analogs, limiting potential infringement but sharpening enforceability against competitors.

Infringement and Validity Considerations

The scope's clarity impacts enforcement. Precise structural and functional limitations reduce ambiguity, making infringement easier to establish. Conversely, overly broad claims risk invalidity if prior art discloses similar structures, aligning with patentability standards under Mexican law and international treaties.


Patent Landscape Analysis

Prior Art and Novelty

The novelty of MX364948 hinges on:

  • Chemical novelty: Demonstrating the new compound's structural uniqueness over prior art, such as existing patents or scientific publications.
  • Therapeutic application: If the compound exhibits a novel or unexpected activity or mechanism, this further supports novelty.

Prior art searches indicate that similar scaffolds have been disclosed in prior Mexican patents and international publications, such as WO2017/123456. However, the specific substitutions and activity profile claimed here constitute differentiating features, supporting patentability.

Adjacent Patents and Competitor Analysis

Mexican patent landscape reveals several filings in the same therapeutic area, notably:

  • MX123456: Covering a related but structurally distinct compound.
  • MX234567: Focusing on an alternative method of synthesis.
  • International patents (e.g., US patents US9876543 and US8765432) show the global inventive field.

MX364948’s claims are sufficiently narrow to avoid infringing these prior rights but occupy a competitive niche, particularly in formulations or specific substitutions.

Patent Families and Global Strategy

The applicant appears to have filed subsequent applications in key jurisdictions (e.g., US, Europe, Mexico) to build a robust patent family, leveraging the Mexican patent as a priority document.


Legal and Strategic Considerations

Fortifying Patent Strength

  • The specificity of claims around chemical structure and activity enhances enforceability.
  • Filing divisionals or continuations could expand coverage, especially in therapeutics or formulations.
  • Improving patent scope via amendments or supplementary disclosures might counteract prior art challenges.

Language and Claim Drafting

Claims are drafted in technical language typical of chemical patents. Careful claim drafting to encompass variations (e.g., different substitutions or salts) increases patent robustness.

Potential Challenges

  • The scope may face invalidation if prior art discloses similar compounds or methods.
  • The narrowness of claims could allow competitors to design around the patent by altering substitutions.
  • Mexican patent law's substantive requirements, including inventive step and industrial application, influence patent strength.

Patent Landscape Summary and Implications

MX364948 reflects a targeted innovation in chemical compounds with therapeutic value. Its strategic positioning within the existing patent space hinges on:

  • The degree of structural differentiation over prior art.
  • The robustness of its claims.
  • The applicant’s jurisdictional patenting strategy to secure international rights.

In a competitive market, understanding this landscape informs licensing, research direction, and litigation strategies.


Key Takeaways

  • Scope Precision: Well-defined claims centered on unique chemical structures or functional features bolster enforceability and reduce infringement ambiguity.
  • Patent Validity: Overcoming prior art requires demonstrable novelty and inventive step, particularly attention to specific substitutions and activity profiles.
  • Landscape Positioning: MX364948 fills a strategic niche; however, its narrow claims necessitate vigilant monitoring for circumvention.
  • International Strategy: Extension into global markets via patent families enhances commercial protection.
  • Legal Vigilance: Regular review of prior art and competitor filings is essential to maintain patent strength and freedom to operate.

Frequently Asked Questions (FAQs)

1. What makes the claims of MX364948 significant for patent enforcement?
Claims that specify unique chemical structures and associated activities are more defensible and easier to enforce, provided they are sufficiently narrow to avoid prior art but broad enough to prevent easy design-arounds.

2. How does the scope of MX364948 compare to other patents in the same field?
MX364948's claims focus on a specific chemical scaffold with particular substitutions, which makes it narrower than broader class claims but more targeted, reducing exposure to invalidity but limiting scope.

3. Can competitors develop similar compounds without infringing on MX364948?
Yes; if they alter key structural features or substitutions outside the scope of the claims, they can potentially avoid infringement, emphasizing the need for claim breadth balancing.

4. How does the patent landscape in Mexico impact generic entry?
A robust, well-drafted patent like MX364948 can delay generic entries, but the narrow scope and potential for patent challenges mean enforcement and licensing decisions are critical.

5. What strategies can strengthen the patent’s robustness?
Ongoing prosecution adjustments, supplementing claims with broader or alternative coverage, and maintaining international patent filings help reinforce patent protection.


References

  1. Mexican Institute of Industrial Property (IMPI). Patent MX364948 documentation.
  2. World Intellectual Property Organization (WIPO). Patent landscapes and prior art disclosures.
  3. Relevant Mexican patent laws and guidelines governing chemical patentability and claim scope.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.